605 related articles for article (PubMed ID: 30619311)
1. Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools.
Wienke J; Deakin CT; Wedderburn LR; van Wijk F; van Royen-Kerkhof A
Front Immunol; 2018; 9():2951. PubMed ID: 30619311
[TBL] [Abstract][Full Text] [Related]
2. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.
Kim H; Gunter-Rahman F; McGrath JA; Lee E; de Jesus AA; Targoff IN; Huang Y; O'Hanlon TP; Tsai WL; Gadina M; Miller FW; Goldbach-Mansky R; Rider LG
Arthritis Res Ther; 2020 Apr; 22(1):69. PubMed ID: 32252809
[TBL] [Abstract][Full Text] [Related]
3. Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment.
Wu JQ; Lu MP; Reed AM
World J Pediatr; 2020 Feb; 16(1):31-43. PubMed ID: 31556011
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary function and autoantibodies in a long-term follow-up of juvenile dermatomyositis patients.
Mathiesen PR; Buchvald F; Nielsen KG; Herlin T; Friis T; Nielsen S
Rheumatology (Oxford); 2014 Apr; 53(4):644-9. PubMed ID: 24310298
[TBL] [Abstract][Full Text] [Related]
5. Expression of myxovirus-resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis.
Soponkanaporn S; Deakin CT; Schutz PW; Marshall LR; Yasin SA; Johnson CM; Sag E; Tansley SL; McHugh NJ; Wedderburn LR; Jacques TS
Neuropathol Appl Neurobiol; 2019 Jun; 45(4):410-420. PubMed ID: 29770465
[TBL] [Abstract][Full Text] [Related]
6. Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study.
Tansley SL; Betteridge ZE; Gunawardena H; Jacques TS; Owens CM; Pilkington C; Arnold K; Yasin S; Moraitis E; Wedderburn LR; McHugh NJ;
Arthritis Res Ther; 2014 Jul; 16(4):R138. PubMed ID: 24989778
[TBL] [Abstract][Full Text] [Related]
7. Updates on Juvenile Dermatomyositis from the Last Decade: Classification to Outcomes.
Kim H; Huber AM; Kim S
Rheum Dis Clin North Am; 2021 Nov; 47(4):669-690. PubMed ID: 34635298
[TBL] [Abstract][Full Text] [Related]
8. The Vasculopathy of Juvenile Dermatomyositis.
Papadopoulou C; McCann LJ
Front Pediatr; 2018; 6():284. PubMed ID: 30356795
[TBL] [Abstract][Full Text] [Related]
9. Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis.
Gitiaux C; De Antonio M; Aouizerate J; Gherardi RK; Guilbert T; Barnerias C; Bodemer C; Brochard-Payet K; Quartier P; Musset L; Chazaud B; Desguerre I; Bader-Meunier B
Rheumatology (Oxford); 2016 Mar; 55(3):470-9. PubMed ID: 26424834
[TBL] [Abstract][Full Text] [Related]
10. Juvenile dermatomyositis: advances in pathogenesis, evaluation, and treatment.
Huber AM
Paediatr Drugs; 2009; 11(6):361-74. PubMed ID: 19877722
[TBL] [Abstract][Full Text] [Related]
11. Lung infection or inflammation-a puzzling case of MDA-5 associated juvenile dermatomyositis.
Vuppala A; Sondhi M; Umer S
Pediatr Rheumatol Online J; 2023 Dec; 21(1):147. PubMed ID: 38124190
[TBL] [Abstract][Full Text] [Related]
12. Myogenic Progenitor Cells Exhibit Type I Interferon-Driven Proangiogenic Properties and Molecular Signature During Juvenile Dermatomyositis.
Gitiaux C; Latroche C; Weiss-Gayet M; Rodero MP; Duffy D; Bader-Meunier B; Glorion C; Nusbaum P; Bodemer C; Mouchiroud G; Chelly J; Germain S; Desguerre I; Chazaud B
Arthritis Rheumatol; 2018 Jan; 70(1):134-145. PubMed ID: 28941175
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
[TBL] [Abstract][Full Text] [Related]
14. Association of anti-TPM4 autoantibodies with vasculopathic cutaneous manifestations in juvenile dermatomyositis.
Karasawa R; Yudoh K; Sato T; Tanaka M; Sabbagh SE; Flegel WA; Mammen AL; Jarvis JN; Rider LG;
Rheumatology (Oxford); 2023 Nov; 62(11):3757-3762. PubMed ID: 37144941
[TBL] [Abstract][Full Text] [Related]
15. Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis.
Preuße C; Allenbach Y; Hoffmann O; Goebel HH; Pehl D; Radke J; Doeser A; Schneider U; Alten RH; Kallinich T; Benveniste O; von Moers A; Schoser B; Schara U; Stenzel W
Acta Neuropathol Commun; 2016 Apr; 4(1):45. PubMed ID: 27121733
[TBL] [Abstract][Full Text] [Related]
16. Recent research on myositis-specific autoantibodies in juvenile dermatomyositis.
He L
Zhongguo Dang Dai Er Ke Za Zhi; 2021 Oct; 23(10):1064-1068. PubMed ID: 34719424
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and poor predictors of anti-NXP2 antibody-associated Chinese JDM children.
Wang X; Ding Y; Zhou Z; Hou J; Xu Y; Li J
Pediatr Rheumatol Online J; 2021 Jan; 19(1):6. PubMed ID: 33407621
[TBL] [Abstract][Full Text] [Related]
18. Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis.
Mammen AL
Ann N Y Acad Sci; 2010 Jan; 1184():134-53. PubMed ID: 20146695
[TBL] [Abstract][Full Text] [Related]
19. Association of anti-HSC70 autoantibodies with cutaneous ulceration and severe disease in juvenile dermatomyositis.
Karasawa R; Yudoh K; Sato T; Tanaka M; Tamaki M; Sabbagh SE; O'Hanlon TP; Noroozi-Farhadi P; Targoff IN; Flegel WA; Mammen AL; Miller FW; Hicar MD; Rider LG; Jarvis JN
Rheumatology (Oxford); 2022 Jul; 61(7):2969-2977. PubMed ID: 34791087
[TBL] [Abstract][Full Text] [Related]
20. MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: association with muscle involvement.
O'Connor KA; Abbott KA; Sabin B; Kuroda M; Pachman LM
Clin Immunol; 2006 Sep; 120(3):319-25. PubMed ID: 16859997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
